CTC Based Cancer Detection and Diagnosis

Not Applicable

• Conditions: Health Condition 1: C00-D49- Neoplasms

• Registration Number: CTRI/2022/02/040373
• Lead Sponsor: Datar Cancer Genetics Private Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Adult males and females, aged 18 years and above,

2.Provision of Informed Consent,

3.Willing and able to participate in the study and provide blood sample.

4.No co-morbidities which could impair study participation or procedures,

5.No prior diagnosis of any cancer,

6.Suspected of primary malignancy of either the brain, breast, lung, prostate, pancreas, bile duct or gallbladder, and posted to undergo an invasive biopsy as part of standard diagnostic procedures.

Exclusion Criteria

1.Failure to meet Inclusion Criteria,

2.Age less than 18 years,

3.Inability to provide Informed Consent,

4.Co-morbidities which could impair study participation or sample collection,

5.Positive for HIV / HBV / HCV,

6.Prior diagnosis of any malignancy,

7.Unable to undergo an invasive biopsy as part of standard diagnostic procedures.

8.Suspicion of hematological, lymphoid or myeloid malignancies.

Study & Design

• Study Type: Observational
• Study Design: Not specified